Menu
  • Video
  • Audio
  • Images
  • Collections
  • About
Sign in
ASRS A project from the American Soceity of Retina Specialists
Share feedback      Sign in
ASRS Multimedia Library
ASRS A project from the American Society of Retina Specialists
Search by condition, keyword, or author name
  • Video
  • Audio
  • Images
  • Collections
  • About
  1. Collections
  2. Annual Meeting Talks

Sign in to view content

Sign in

Brolucizumab for the Treatment of Visual Impairment Due to Diabetic Macular Edema: 52-Week Results From the KESTREL and KITE Studies

  • David M. Brown, MD
  • Video
  • Published 2021

Related

  • Brolucizumab in HAWK/HARRIER: Outcomes, Efficacy, & Dosing Status – Everything You Need to Know!

    David M. Brown, MD

    Updates from the Field

    2018

  • Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian DME Patients in a Real-World Setting: The PRECISE Study

    Michel R Giunta, MD

    On Demand Cases, Courses, and Papers

    2021

  • Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian nAMD and DME Patients in a Real-World Setting: The PRECISE Study

    Ananda Kalevar, MD, FRCS(C), DABO

    On Demand Cases, Courses, and Papers

    2020

Category: Diabetic Retinopathy

  • brolucizumab
  • DME
  • Phase III
  • KESTREL
  • KITE

See more

  • Annual Meeting Talks
  • David M. Brown, MD
  • ASRS Multimedia Library
  • Video
  • Audio
  • Images
  • Collections
American Society of Retina Specialists20 North Wacker Drive, Suite 2030,Chicago, Illinois 60606(312) 578-8760 phoneinfo@asrs.org
© 2025 The American Society of Retina Specialists. All rights reserved. Privacy statement. Terms of use.